Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had revenue of 7.91M SEK in the quarter ending September 30, 2025, with 3,285.70% growth. This brings the company's revenue in the last twelve months to 13.70M, up 219.62% year-over-year. In the year 2024, Elicera Therapeutics AB had annual revenue of 7.13M, down -36.52%.

• Revenue (ttm): 13.70M
• Revenue Growth: +219.62%
• P/S Ratio: 17.83
• Revenue / Employee: 6.85M
• Employees: 2
• Market Cap: 244.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.13M	-4.10M	-36.52%
Dec 31, 2023	11.23M	9.95M	777.23%
Dec 31, 2022	1.28M	1.28M	217,987.39%
Dec 31, 2021	587.00	-	-
Dec 31, 2020	-	-	-